FDA will have to decide on an Alzheimer's medication that is made specifically for elderly people who are still in the early stages of the disease.
FDA broadened Xolair drug approval for more subjects with food hypersensitivity, the medication that has prevented anaphylaxis attacks in multiple food allergies.